Want to see ALLO full AI Analyst Report?
Allogene Therapeutics (ALLO) Hedge Fund Trading Activity
Trend: â–² Hedge Funds Increased Holdings by 16.9M Shares Last Quarter
Hedge Fund Holdings in ALLO
Based on the 13F filings of 488 Hedge Funds submitted to the SEC.
Hedge Fund Confidence Signal
Hedge Fund Activity​
Activity
Star Ranking
| Hedge Fund Manager | Star Ranking | Firm | Activity | Holding Change | Value Reported | % of Portfolio | Follow |
|---|---|---|---|---|---|---|---|
| Graham Capital Management, L.P. | Added | 164.47% | $237,992 | <0.01% | |||
| Not Ranked | Added | 57.91% | $62,705,683 | <0.01% | |||
| PRIMECAP Management Co | Added | 56.61% | $27,296,755 | 0.02% | |||
| Woodline Partners LP | Added | 28.55% | $9,361,298 | 0.03% | |||
| Wildcat Capital Management, Llc | Not Changed | 0.00% | $6,075,237 | 2.66% | |||
| Caxton Associates LP | Not Changed | 0.00% | $429,270 | 0.01% |
FAQ
Which hedge funds hold Allogene Therapeutics?
The hedge funds that hold the most shares in Allogene Therapeutics are BlackRock, Inc., Kenneth Tropin and Michael Rockefeller.
Are hedge funds buying or selling ALLO?
In the last quarter hedge funds have Increased their holdings in Allogene Therapeutics by 16.9M shares.
Where can I see a list of the best rated hedge funds?
You can see a list of the best hedge funds here.
Who is the best-performing hedge fund manager?
The top-rated hedge fund managers can be seen here: Top Hedge Fund Managers
Does Warren Buffet hold shares in Allogene Therapeutics stock?
Warren Buffet currently does not own shares in Allogene Therapeutics.
What is a 13F filing, and how does it help investors?
A 13F form, also known as a "Report of Investment Manager," is a quarterly report that investment advisors registered with the Securities and Exchange Commission (SEC) must file if they manage at least $100 million in assets. The 13F form lists all of the publicly traded securities that the investment advisor owns as of the end of the reporting period. To read more about the 13F, click here